Testicular lymphoma: A case report

BENAMAR Mohammed *, CHEIKH Mohamed, TALEB Omar, AHSAINI Mustapha, MELLAS Soufiane, TAZI Mohamed Fadl, EL AMMARI Jalal Eddine, EL FASSI Mohammed Jamal and FARIH Moulay Hassan

Urology Department, Chu Hassan II, Fes, Morocco.
 
Case Study
World Journal of Advanced Research and Reviews, 2023, 20(02), 656–659
Article DOI10.30574/wjarr.2023.20.2.2220
 
Publication history: 
Received on 22 September 2023; revised on 05 November 2023; accepted on 07 November 2023
 
Abstract: 
Primary testicular lymphoma (PTTL) is a rare and aggressive form of extraganglionic malignant non-Hodgkin's lymphoma (NML). It accounts for 1% of malignant non-Hodgkin's lymphomas, 2% of extranodal lymphomas and 5% of malignant testicular tumours. LTP is the most common form of testicular malignancy in men over 60.  An enlarged inguinal orchiectomy should be performed for diagnostic and therapeutic purposes(1). Adjuvant treatment is based on systemic chemotherapy, administration of rituximab in the presence of CD20+ cells and intrathecal injection of methotrexate for neuro-meningeal prophylaxis.
In this article, we report a case of testicular lymphoma in a 73-year-old patient who underwent inguinal orchiectomy followed by systemic and intrathecal CHOP chemotherapy.
 
Keywords: 
Testicular lymphoma; Chemotherapy; CHOP; Adjuvant treatment; Methotrexate.
 
Full text article in PDF: 
Share this